Whole genome sequencing of metastatic melanomas from a patient with primary resistance to BRAF inhibition

Here, we investigated the underlying cause of treatment failure in a patient with BRAF mutant melanoma who presented primary resistance. We used whole-genome sequencing (WGS) to characterise five metastatic tumours from a BRAF mutant melanoma patient who presented intrinsic resistance.EGA study EGAS00001000580